U. Klotz

Drug metabolism reviews (Softcover ed.) · 2009

A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Whom U. Klotz trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. S. Reitmanova
  2. S. Sim

Papers from U. Klotz's perspective

Ordered by how strongly the researchers U. Klotz trusts endorse each paper. Same corpus, a different order for every researcher.

  1. A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants (Clinical pharmacology and therapy)
  2. Role of P-Glycoprotein in Pharmacokinetics (Clinical Pharmacokinetics)
  3. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. (Proceedings of the National Academy of Sciences of the United States of America)
  4. Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response (Molecular Psychiatry)
  5. Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism (Clinical Pharmacokinetics)
  6. Identification of functionally variant MDR1 alleles among European Americans and African Americans (Clinical pharmacology and therapy)
  7. Frequency of single nucleotide polymorphisms in the P‐glycoprotein drug transporter MDR1 gene in white subjects (Clinical pharmacology and therapy)
  8. ABC proteins : from bacteria to man
  9. Changes in plasma protein binding have little clinical relevance (Clinical pharmacology and therapy)
  10. Biology of Aging (Reihe der Villa Vigoni)

Their papers